Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2013

01-08-2013 | Review

Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection

Author: Robério Amorim de Almeida Pondé

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2013

Login to get access

Abstract

The diagnosis of hepatitis C virus (HCV) infection is defined according to the results obtained from screening assays, and confirmation made by supplemental tests, in order to exclude the possibility of false-positive and false-negative results and, therefore, a misdiagnosis. Identifying the patient’s true clinical status is of crucial importance to direct an accurate course of therapy, but, often, the definition of this status is only possible after conjunctions and analysis of the results obtained from each methodology applied, considering the limitations of each assay. In this manuscript, it is discussed briefly the possible results obtained from the three methods most commonly applied in routine laboratory and their contribution in the diagnosis of HCV infection.
Literature
1.
go back to reference Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20(1):1–16PubMedCrossRef Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20(1):1–16PubMedCrossRef
2.
go back to reference Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV (1975) Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292(15):767–770PubMedCrossRef Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV (1975) Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292(15):767–770PubMedCrossRef
3.
go back to reference Rosen HR, Pawlotsky JM (2003) Scientific advances in hepatitis C virus. Clin Liver Dis 7:xiii–xvCrossRef Rosen HR, Pawlotsky JM (2003) Scientific advances in hepatitis C virus. Clin Liver Dis 7:xiii–xvCrossRef
4.
go back to reference Centers for Disease Control and Prevention (CDC) (1991) Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Recomm Rep 40(RR-4):1–17 Centers for Disease Control and Prevention (CDC) (1991) Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Recomm Rep 40(RR-4):1–17
6.
go back to reference Kiely P, Kay D, Parker S, Piscitelli L (2004) The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. Transfusion 44(3):349–358PubMedCrossRef Kiely P, Kay D, Parker S, Piscitelli L (2004) The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. Transfusion 44(3):349–358PubMedCrossRef
7.
go back to reference Alter M, Kuhnert WL, Finelli L; Centers for Disease Control and Prevention (2003) Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 52(RR-3):1–15PubMed Alter M, Kuhnert WL, Finelli L; Centers for Disease Control and Prevention (2003) Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 52(RR-3):1–15PubMed
8.
go back to reference Alborino F, Burighel A, Tiller FW, van Helden J, Gabriel C, Raineri A, Catapano R, Stekel H (2011) Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity. Med Microbiol Immunol 200(2):77–83PubMedCrossRef Alborino F, Burighel A, Tiller FW, van Helden J, Gabriel C, Raineri A, Catapano R, Stekel H (2011) Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity. Med Microbiol Immunol 200(2):77–83PubMedCrossRef
9.
go back to reference Kamili S, Drobeniuc J, Araujo AC, Hayden TM (2012) Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis 55(Suppl 1):S43–S48PubMedCrossRef Kamili S, Drobeniuc J, Araujo AC, Hayden TM (2012) Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis 55(Suppl 1):S43–S48PubMedCrossRef
10.
go back to reference Bux-Gewehr I, Schmandt S, Zotz RB, Scharf RE, Roggendorf M (2001) Long-term hepatitis C seroconversion in a blood donor. Transfusion 41(3):427PubMedCrossRef Bux-Gewehr I, Schmandt S, Zotz RB, Scharf RE, Roggendorf M (2001) Long-term hepatitis C seroconversion in a blood donor. Transfusion 41(3):427PubMedCrossRef
11.
go back to reference Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M (2007) HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors. J Clin Virol 39:282–287PubMedCrossRef Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M (2007) HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors. J Clin Virol 39:282–287PubMedCrossRef
12.
go back to reference Tobler LH, Stramer SL, Kleinman SH, Brodsky JP, Todd DS, Busch MP (2001) Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity. Transfusion 41:1625–1626PubMedCrossRef Tobler LH, Stramer SL, Kleinman SH, Brodsky JP, Todd DS, Busch MP (2001) Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity. Transfusion 41:1625–1626PubMedCrossRef
13.
go back to reference Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, Changchien CS (2004) Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? J Viral Hepat 11(6):563–570PubMedCrossRef Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, Changchien CS (2004) Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? J Viral Hepat 11(6):563–570PubMedCrossRef
14.
go back to reference Kesli R, Ozdemir M, Kurtoglu MG, Baykan M, Baysal B (2009) Evaluation and comparison of three different anti-hepatitis C virus antibody tests based on chemiluminescence and enzyme-linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey. J Int Med Res 37(5):1420–1429PubMedCrossRef Kesli R, Ozdemir M, Kurtoglu MG, Baykan M, Baysal B (2009) Evaluation and comparison of three different anti-hepatitis C virus antibody tests based on chemiluminescence and enzyme-linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey. J Int Med Res 37(5):1420–1429PubMedCrossRef
15.
go back to reference Vernelen K, Claeys H, Verhaert H, Volckaerts A, Vermylen C (1994) Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 343:853PubMedCrossRef Vernelen K, Claeys H, Verhaert H, Volckaerts A, Vermylen C (1994) Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 343:853PubMedCrossRef
16.
go back to reference Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH (2002) Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 7(40):2408–2419CrossRef Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH (2002) Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 7(40):2408–2419CrossRef
17.
go back to reference Margaritis AR, Brown SM, Seed CR, Kiely P, D’Agostino B, Keller AJ (2007) Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 47:1783–1793PubMedCrossRef Margaritis AR, Brown SM, Seed CR, Kiely P, D’Agostino B, Keller AJ (2007) Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 47:1783–1793PubMedCrossRef
18.
go back to reference Carreño V, Bartolomé J, Castillo I, Quiroga JÁ (2012) New perspectives in occult hepatitis C virus infection. World J Gastroenterol 18(23):2887–2894PubMedCrossRef Carreño V, Bartolomé J, Castillo I, Quiroga JÁ (2012) New perspectives in occult hepatitis C virus infection. World J Gastroenterol 18(23):2887–2894PubMedCrossRef
19.
go back to reference Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V (2011) Long-term virological follow up of patients with occult hepatitis C virus infection. Liver Int 31(10):1519–1524PubMedCrossRef Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V (2011) Long-term virological follow up of patients with occult hepatitis C virus infection. Liver Int 31(10):1519–1524PubMedCrossRef
20.
go back to reference Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R (2001) Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol 4(39):1665–1668CrossRef Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R (2001) Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol 4(39):1665–1668CrossRef
21.
go back to reference Suslov AP, Kuzin SN, Golosova TV, Shalunova NV, Malyshev NA, Sadikova NV, Vavilova LM, Somova AV, Musina EE, Ivanova MV, Kipor TT, Timonin IM, Kuzina LE, Godkov MA, Bajenov AI, Nesterenko VG (2002) Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay. Russ J Immunol 7(2):175–184PubMed Suslov AP, Kuzin SN, Golosova TV, Shalunova NV, Malyshev NA, Sadikova NV, Vavilova LM, Somova AV, Musina EE, Ivanova MV, Kipor TT, Timonin IM, Kuzina LE, Godkov MA, Bajenov AI, Nesterenko VG (2002) Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay. Russ J Immunol 7(2):175–184PubMed
22.
go back to reference Berger A, Rabenau H, Allwinn R, Doerr HW (2008) Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. J Clin Virol 43(2):158–161PubMedCrossRef Berger A, Rabenau H, Allwinn R, Doerr HW (2008) Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. J Clin Virol 43(2):158–161PubMedCrossRef
Metadata
Title
Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection
Author
Robério Amorim de Almeida Pondé
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-013-1857-1

Other articles of this Issue 8/2013

European Journal of Clinical Microbiology & Infectious Diseases 8/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.